PT730608E - Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes - Google Patents
Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoesInfo
- Publication number
- PT730608E PT730608E PT94917961T PT94917961T PT730608E PT 730608 E PT730608 E PT 730608E PT 94917961 T PT94917961 T PT 94917961T PT 94917961 T PT94917961 T PT 94917961T PT 730608 E PT730608 E PT 730608E
- Authority
- PT
- Portugal
- Prior art keywords
- complement
- compositions
- producing
- methods
- proeins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Carbon And Carbon Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6198293A | 1993-05-17 | 1993-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT730608E true PT730608E (pt) | 2002-09-30 |
Family
ID=22039478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94917961T PT730608E (pt) | 1993-05-17 | 1994-05-12 | Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes |
Country Status (11)
Country | Link |
---|---|
US (1) | US6193979B1 (pt) |
EP (1) | EP0730608B1 (pt) |
JP (1) | JP3662021B2 (pt) |
AT (1) | ATE215094T1 (pt) |
CA (1) | CA2162600C (pt) |
DE (1) | DE69430253T2 (pt) |
DK (1) | DK0730608T3 (pt) |
ES (1) | ES2174876T3 (pt) |
PT (1) | PT730608E (pt) |
SG (1) | SG52383A1 (pt) |
WO (1) | WO1994026786A1 (pt) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT730608E (pt) | 1993-05-17 | 2002-09-30 | Avant Immunotherapeutics Inc | Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes |
DE69534701T2 (de) | 1994-09-23 | 2006-10-19 | Alexion Pharmaceuticals, Inc., Cheshire | Verfahren zur behandlung von entzündlichen gelenkerkrankungen |
GB9614871D0 (en) | 1996-07-15 | 1996-09-04 | Smithkline Beecham Plc | Compounds |
WO1999037149A1 (en) | 1998-01-27 | 1999-07-29 | Brigham & Women's Hospital | Methods of treating cytotoxic damage |
GB9905503D0 (en) * | 1999-03-10 | 1999-05-05 | Adprotech Plc | Novel compound formulations and methods of delivery |
JP5183010B2 (ja) | 2002-05-16 | 2013-04-17 | グリコミメティクス, インコーポレイテッド | セレクチンによって媒介される機能を阻害するための化合物および方法 |
JP2006502986A (ja) * | 2002-07-03 | 2006-01-26 | グリコミメティクス, インコーポレイテッド | 新脈管形成に関与する医学的状態の診断および治療のための組成物および方法 |
US20040219158A1 (en) * | 2003-05-02 | 2004-11-04 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria |
FR2861729B1 (fr) * | 2003-10-31 | 2006-09-08 | Fabre Pierre Dermo Cosmetique | Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur |
EP1685145A2 (en) * | 2003-11-19 | 2006-08-02 | GlycoMimetics, Inc. | Glycomimetic antagonists for both e- and p-selectins |
US7361644B2 (en) * | 2003-11-19 | 2008-04-22 | Glycomimetics, Inc. | Specific antagonist for both E- and P-selectins |
US8201377B2 (en) * | 2004-11-05 | 2012-06-19 | Faus Group, Inc. | Flooring system having multiple alignment points |
WO2006127906A1 (en) * | 2005-05-25 | 2006-11-30 | Glycomimetics, Inc. | Heterobifunctional compounds for selectin inhibition |
WO2006131874A2 (en) * | 2005-06-06 | 2006-12-14 | Univ Cape Town | Methods for treatment or prophylaxis of atherosclerosis and reperfusion injury |
US20070004625A1 (en) * | 2005-06-30 | 2007-01-04 | Li Liang-Man | Use of complement inhibitory proteins to treat spinal cord injury |
EP1738763A1 (en) | 2005-06-30 | 2007-01-03 | AVANT Immunotherapeutics, Inc. | Use of complement inhibitory proteins to treat spinal cord injury |
ES2375979T3 (es) * | 2005-08-09 | 2012-03-07 | Glycomimetics, Inc. | Inhibidores glicomiméticos de la lectina pa-il, lectina pa-iil o ambas lectinas de pseudomonas. |
DK2264043T3 (da) | 2005-09-02 | 2018-01-29 | Glycomimetics Inc | Heterobifunktionelle pan-selektin-inhibitorer |
US20090176717A1 (en) * | 2006-06-01 | 2009-07-09 | Glycomimetics, Inc. | Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
CA2666103C (en) | 2006-10-12 | 2014-02-18 | Glycomimetics, Inc. | Glycomimetic replacements for hexoses and n-acetyl hexosamines |
EP2083841B1 (en) * | 2006-10-20 | 2013-11-20 | Celldex Therapeutics, Inc. | SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1) PROTEIN FOR USE IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER DISEASES OF THE EYE |
EP2117561A1 (en) * | 2007-02-09 | 2009-11-18 | GlycoMimetics, Inc. | Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
US8039442B2 (en) | 2007-07-18 | 2011-10-18 | Glycomimetics, Inc. | Compounds and methods for treatment of sickle cell disease or complications associated therewith |
US8895510B2 (en) * | 2008-04-08 | 2014-11-25 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
WO2009152245A1 (en) * | 2008-06-13 | 2009-12-17 | Glycomimetics, Inc. | Treatment of cancers of the blood using selected glycomimetic compounds |
AU2010241807B2 (en) | 2009-05-01 | 2014-08-14 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors |
US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
US9295713B2 (en) | 2010-09-15 | 2016-03-29 | Celldex Therapeutics, Inc. | Treatment of chronic nephropathies using soluble complement receptor type I (sCR1) |
EP2632476B1 (en) | 2010-10-27 | 2017-06-14 | Celldex Therapeutics, Inc. | Method of improving transplant function using soluble complement receptor type i (scr1) |
KR102055958B1 (ko) | 2011-12-22 | 2019-12-13 | 글리코미메틱스, 인크. | E-셀렉틴 길항제 화합물, 조성물, 및 이용 방법 |
US9867841B2 (en) | 2012-12-07 | 2018-01-16 | Glycomimetics, Inc. | Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells |
WO2015103438A2 (en) | 2014-01-02 | 2015-07-09 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
JP6689854B2 (ja) | 2014-12-03 | 2020-04-28 | グリコミメティクス, インコーポレイテッド | E−セレクチンおよびcxcr4ケモカイン受容体のヘテロ二官能性阻害剤 |
CA3009836A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
WO2017151708A1 (en) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin |
EP3497131B1 (en) | 2016-08-08 | 2022-03-09 | GlycoMimetics, Inc. | Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4. |
KR102607640B1 (ko) | 2016-10-07 | 2023-11-28 | 글리코미메틱스, 인크. | 매우 강력한 다량체성 e-셀렉틴 길항물질 |
US11197877B2 (en) | 2017-03-15 | 2021-12-14 | Glycomimetics. Inc. | Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists |
EP3717013A1 (en) | 2017-11-30 | 2020-10-07 | GlycoMimetics, Inc. | Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
AU2018395417B2 (en) | 2017-12-29 | 2023-07-13 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
CA3091454A1 (en) | 2018-03-05 | 2019-09-12 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
KR20210013091A (ko) | 2018-05-16 | 2021-02-03 | 시에스엘 리미티드 | 가용성 보체 수용체 1형 변이체 및 이의 용도 |
US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
US20210371534A1 (en) * | 2020-06-01 | 2021-12-02 | Musc Foundation For Research Development | Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5212071A (en) | 1988-04-01 | 1993-05-18 | The Johns Hopkins University | Nucleic acids encoding a human C3b/C4b receptor (CR1) |
US4752569A (en) | 1984-06-21 | 1988-06-21 | The Regents Of The University Of California | Sialylated Lewisx epitope, antibodies and diagnosis |
IL82390A0 (en) | 1986-05-02 | 1987-10-30 | Genentech Inc | Nucleic acid and methods for the synthesis of novel daf compositions |
US5079353A (en) | 1987-12-02 | 1992-01-07 | Chembiomed, Ltd. | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
US5081034A (en) | 1988-11-14 | 1992-01-14 | Brigham & Women's Hospital | Cloned genes which encode elam-1 |
JPH05501359A (ja) | 1990-04-27 | 1993-03-18 | バイオジェン,インコーポレイテッド | 付着分子発現に関与するフコシルトランスフェラーゼ |
WO1991019501A1 (en) | 1990-06-15 | 1991-12-26 | Cytel Corporation | Intercellular adhesion mediators |
DE69133120T2 (de) | 1990-07-17 | 2003-05-15 | Univ Oklahoma Norman Board Of | GMP-140 Ligand |
US5211937A (en) | 1990-07-30 | 1993-05-18 | Glycomed Incorporated | Method of determining a site of inflammation utilizing elam-1 ligands |
US5164374A (en) | 1990-12-17 | 1992-11-17 | Monsanto Company | Use of oligosaccharides for treatment of arthritis |
US5166133A (en) | 1991-04-17 | 1992-11-24 | Cetus Corporation | Method for inhibing adhesion of white blood cells to endothelial cells |
EP0512733A2 (en) | 1991-05-03 | 1992-11-11 | Washington University | Modified complement system regulator |
JP3859697B2 (ja) | 1991-05-06 | 2006-12-20 | ジェネンテック・インコーポレーテッド | セレクチンリガンド |
US5227369A (en) | 1991-07-11 | 1993-07-13 | The Regents Of The University Of California | Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
US5456909A (en) * | 1992-08-07 | 1995-10-10 | T Cell Sciences, Inc. | Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo |
PT730608E (pt) | 1993-05-17 | 2002-09-30 | Avant Immunotherapeutics Inc | Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes |
US5856300A (en) * | 1994-05-12 | 1999-01-05 | T Cell Sciences, Inc. | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
-
1994
- 1994-05-12 PT PT94917961T patent/PT730608E/pt unknown
- 1994-05-12 WO PCT/US1994/005285 patent/WO1994026786A1/en active IP Right Grant
- 1994-05-12 CA CA002162600A patent/CA2162600C/en not_active Expired - Fee Related
- 1994-05-12 AT AT94917961T patent/ATE215094T1/de not_active IP Right Cessation
- 1994-05-12 DE DE69430253T patent/DE69430253T2/de not_active Expired - Fee Related
- 1994-05-12 JP JP52569594A patent/JP3662021B2/ja not_active Expired - Fee Related
- 1994-05-12 DK DK94917961T patent/DK0730608T3/da active
- 1994-05-12 EP EP94917961A patent/EP0730608B1/en not_active Expired - Lifetime
- 1994-05-12 ES ES94917961T patent/ES2174876T3/es not_active Expired - Lifetime
- 1994-05-12 SG SG1996003777A patent/SG52383A1/en unknown
-
1995
- 1995-05-25 US US08/450,274 patent/US6193979B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
SG52383A1 (en) | 1998-09-28 |
DK0730608T3 (da) | 2002-07-22 |
JPH08510257A (ja) | 1996-10-29 |
EP0730608A4 (en) | 1998-12-02 |
EP0730608B1 (en) | 2002-03-27 |
AU678486B2 (en) | 1997-05-29 |
AU6947594A (en) | 1994-12-12 |
JP3662021B2 (ja) | 2005-06-22 |
ATE215094T1 (de) | 2002-04-15 |
ES2174876T3 (es) | 2002-11-16 |
DE69430253T2 (de) | 2002-11-14 |
US6193979B1 (en) | 2001-02-27 |
CA2162600C (en) | 2000-07-11 |
EP0730608A1 (en) | 1996-09-11 |
WO1994026786A1 (en) | 1994-11-24 |
CA2162600A1 (en) | 1994-11-24 |
DE69430253D1 (de) | 2002-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT730608E (pt) | Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes | |
UA29494C2 (uk) | Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція | |
AR040603A1 (es) | El uso de un anticuerpo anti-tnfalfa neutralizador de alta afinidad en la fabricacion de un medicamento y conjunto de elementos | |
ES2102196T3 (es) | Periferializacion de celulas pluripotenciales hematopoyeticas. | |
FI962154A (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
RU95108231A (ru) | Glp-1-молекулярный комплекс, фармацевтическая композиция и способ получения комплекса | |
NO901986L (no) | Nytt antistoff-leveringssystem for biologisk respons-modifiserende midler. | |
MX9702932A (es) | L-ribofuranosilnucleosidos. | |
YU34196A (sh) | Peptidi i jedinjenja koja se vezuju za receptor | |
DE3587434D1 (de) | Antivirale pharmazeutische zusammensetzungen und ihrer verwendung. | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
BR9910023A (pt) | Conjugados de poliol-ifn-beta | |
AU3572797A (en) | Screening compounds for the ability to alter the production of amyloid-beta peptide (x-$m(g)41) | |
AU6628496A (en) | Polyether block copolymer micellar compositions for targeting biological agents | |
PL323046A1 (en) | Procedures related to arterio-vascular and vascular transplants: method and compositions | |
HK1021539A1 (en) | Androstene derivatives. | |
SE8605295D0 (sv) | Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes | |
ES2009140A6 (es) | Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen. | |
BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
ATE376824T1 (de) | Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln | |
DE69904203D1 (de) | Thiomolybdat verbunden mit mindestens einem kohlenhydrat, und seine verwendung zur vorbeugung und behandlung von erkrankungen, die durch eine anormale vaskularisierung gekennzeichnet sind, wie z.b. krebs, "feuchte" makuladegeneration, rheumatoide arthritis | |
MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
MX9702926A (es) | L-eritrosilnucleosidos. | |
IT8419681A0 (it) | Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche. | |
ES472640A1 (es) | Procedimiento para preparar seudotrisacaridos |